Verona Pharma plc - American Depositary Share (VRNA): Price and Financial Metrics
VRNA Price/Volume Stats
| Current price | $38.85 | 52-week high | $40.13 |
| Prev. close | $38.09 | 52-week low | $11.39 |
| Day low | $37.61 | Volume | 1,409,900 |
| Day high | $39.33 | Avg. volume | 934,647 |
| 50-day MA | $33.30 | Dividend yield | N/A |
| 200-day MA | $21.88 | Market Cap | 3.13B |
VRNA Stock Price Chart Interactive Chart >
Verona Pharma plc - American Depositary Share (VRNA) Company Bio
Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company’s lead product is RPL554, an inhaled dual phosphodiesterase 3 and 4 inhibitor, which is in Phase II clinical trial for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
VRNA Price Returns
| 1-mo | 11.41% |
| 3-mo | 44.53% |
| 6-mo | 222.67% |
| 1-year | 176.51% |
| 3-year | 681.69% |
| 5-year | 922.37% |
| YTD | 95.42% |
| 2023 | -23.92% |
| 2022 | 288.84% |
| 2021 | -4.00% |
| 2020 | 21.74% |
| 2019 | N/A |
Loading social stream, please wait...